Targeted Oncology15h
FDA Clears IND of ADRX-0405, Next-Gen ADC, in Solid Tumors
ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...
Targeted Oncology18h
Roundtable Roundup: Early-Line Use of CAR T-cell Therapy in Multiple Myeloma
In separate, live virtual events, Doris Hansen, MD, and Leyla O. Shune, MD, discuss options for a patient with ...
Targeted Oncology13h
Gupta Discusses T-DM1’s Role in HER2+ Breast Cancer Treatment
Tanya Gupta, MD, discusses the use of ado-trastuzumab emtansine for the treatment of patients with HER2-positive breast cancer.
Targeted Oncology17h
Chemotherapy-Free Regimens Gain Ground in Older Patients With ALL
While there have been exciting advancements in the treatment of B-cell acute lymphoblastic leukemia over the course of the past decade, the treatment of older adults remains a challenge.
Targeted Oncology10h
Opinions on Treatment Split for Prominent Questions in Bladder Cancer
Matthew R. Zibelman, MD, discusses differing opinions in muscle-invasive bladder cancer treatment he heard when moderating a Case-Based Roundtable event.